Beneficial effect of DL-α-lipoic acid on cyclosporine A induced hyperlipidemic nephropathy in rats

Molecular and Cellular Biochemistry

Volumn 301, Issue 1-2, 2007, Pages 165-171

  Amudha, Ganapathy ^a   Josephine, Anthony ^a   Varalakshmi, Palaninathan ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Cyclosporine A; Hyperlipidemia; Lipid metabolizing enzymes; Lipid profile; Lipoic acid; Lipoprotein

Indexed keywords

ANTIOXIDANT; CHOLESTEROL ESTERASE; CYCLOSPORIN A; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; THIOCTIC ACID; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG POTENCY; DYSLIPIDEMIA; ENZYME ACTIVITY; FEEDING; HYPERLIPIDEMIA; KIDNEY DISEASE; LIPID BLOOD LEVEL; LIPID METABOLISM; MALE; NONHUMAN; RAT; TREATMENT OUTCOME;

ANIMALS; ANTIOXIDANTS; CYCLOSPORINE; HUMANS; HYPERLIPIDEMIAS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; LIPID METABOLISM; LIPOPROTEINS; MALE; RATS; RATS, WISTAR; THIOCTIC ACID;

RATTUS; RATTUS NORVEGICUS;

EID: 34250207372     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-006-9408-z     Document Type: Article

References (50)

1. Kasiske BL, Guijarro C, Massy ZA, Wiederkehr MR, Ma JZ (1996) Cardiovascular disease after renal transplantation. J Am Soc Nephrol 7(1):158-165
2. Moore R, Hernandez D, Valantine H (2001) Calcineurin inhibitors and post-transplant hyperlipidaemias. Drug Safety 24:755-766
3. Tse KC, Lam MF, Yip PS, Li FK, Lai KN, Chan TM (2004) A long-term study on hyperlipidemia in stable renal transplant recipients. Clin Transplant 18:274-280
4. Kobashigawa JA, Kasiske BL (1997) Hyperlipidemia in solid organ transplantation. Transplantation 63:331-338
5. Scheuer H, Gwinner W, Hohbach J, Grone EF, Brandes RP, Malle E, Olbricht CJ, Walli AK, Grone HJ (2000) Oxidant stress in hyperlipidemia-induced renal damage. Am J Physiol Renal Physiol 278:F63-74
6. Perico N, Detcheva A, Khalil EI, Remuzzi G (1996) Cyclosporine induces glomerulosclerosis: Three-dimensional definition of the lesions in a rat model of renal transplant. Kidney Int 49:1283-1288
7. Venkiteswaran K, Sgoutas DS, Santanam N, Neylan JF (2001) Tacrolimus, cyclosporine and plasma lipoproteins in renal transplant recipients. Transplant Int 14:405-410
8. Czajkowski K, Wojcicka-Bentyn J, Sienko J, Grymowicz M, Smolarczyk R, Malinowska-Polubiec A, Romejko E (2004) Renal function and lipid metabolism in pregnant renal transplant recipients. Eur J Obstet Gynecol Reprod Biol 114:155-161
9. Vaziri ND, Liang K, Azad H (2000) Effect of cyclosporine on HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, HDL receptor, VLDL receptor, and lipoprotein lipase expressions. J Pharmacol Exp Ther 294:778-783
10. Moghadasian MH (2006) Dietary phytosterols reduce cyclosporine-induced hypercholesterolemia in apolipoprotein E-knockout mice. Transplantation 81:207-213
11. Pannu HS, Singh D, Sandhu JS (2003) Lipid profile before and after renal transplantation-a longitudinal study. Renal Failure 25:411-417
12. Wollin SD, Jones PJ (2003) Alpha-lipoic acid and cardiovascular disease. J Nutr 133:3327-3330
13. Jain SK, Lim G (2000) Lipoic acid decreases lipid peroxidation and protein glycosylation and increases (Na(+) + K(+))- and Ca(++)-ATPase activities in high glucose-treated human erythrocytes. Free Radical Biol Med 29:1122-1128
14. Ivanov VN (1974) Effect of lipoic acid on tissue respiration in rabbits with experimental atherosclerosis. Cor Vasa 16:141-50
15. Baydas G, Yilmaz O, Celik S, Yasar A, Gursu MF (2002) Effects of certain micronutrients and melatonin on plasma lipid, lipid peroxidation, and homocysteine levels in rats. Arch Med Res 33:515-519
16. McCarty MF (1981) An expanded concept of "insurance" supplementation. Broad spectrum protection from cardiovascular diseases. Med Hypotheses 7:1287-302
17. Kocak G, Aktan F, Canbolat O, Ozogul C, Elbeg S, Yildizoglu-Ari N, Karasu C (2000) ADIC Study Group-Antioxidants in Diabetes-Induced Complications Alpha-lipoic acid treatment ameliorates metabolic parameters, blood pressure, vascular reactivity and morphology of vessels already damaged by streptozotocin-diabetes. Diabetes Nutr Metab 13:308-318
18. Malarkodi KP, Balachandar AV, Varlakshmi P (2003) The influence of lipoic acid on adriamycin-induced hyperlipidemic nephrotoxicity in rats. Mol Cell Biochem 247:139-145
19. Mythili Y, Sudharsan PT, Sudhahar V, Varalakshmi P (2006) Protective effect of dl-alpha-lipoic acid on cyclophosphamide induced hyperlipidemic cardiomyopathy. Eur J Pharmacol 543:92-96
20. Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497-509
21. Parekh AC, Jung DH (1970) Cholesterol determination with ferric acetate-uranium acetate and sulphuric acid-ferrous sulfate reagents. Biochim Biophys Acta 42:1423-1427
22. Sperry WM, Webb M (1950) A revision of the schoenheimer-Sperry method for cholesterol determination. J Biol Chem 187:97-106
23. Rice EW (1970) Triglycerides ("neutral fats") in serum. In: MacDonald PR (ed) Standard methods of clinical chemistry Academic Press, New York pp 215-222
24. Hron WT, Menahan LA (1981) A sensitive method for the determination of free fatty acids in plasma. J Lipid Res 22:377-381
25. Rouser G, Fkeischer S, Yamamoto A (1970) Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids 5:494-496
26. Wilson DE, Spiger MJ (1973) A dual precipitation method for quantitative plasma lipoprotein measurement without ultracentrifugation. J Lab Clin Med 82:473-482
27. Kothari HV, Bonner MJ, Miller BF (1970) Cholesterol ester hydrolase in homogenates and lysosomal fractions of human aorta. Biochim Biophys Acta 202:325-331
28. Kritchevsky D, Kothari HV (1973) Aortic cholesterol esterase: Studies in White Carneau and Show Racer pigeons. Biochim Biophys Acta 326:489-491
29. Kothari HV, Miller BF, Kritchevsky D (1973) Aortic cholesterol esterase: characteristics of normal rat and rabbit enzyme. Biochim Biophys Acta 296:446-454
30. Schmidt A (1974) Measurement of lipoprotein lipase and hepatic triglyceride lipase in human postheparin plasma. Methods Enzymol 72:325-337
31. Legraud A, Guillansseav RJ, Land J (1979) Method. Colorimetric simple determination del'actirit, de la lecithin cholesterol acyl transferase (LCAT) plasma fique. Interest on diabetologic. In: Siest G, Glateau MM (eds) Biologic prospective Masson, Paris pp 368-371
32. Hitz J, Steinmetz J, Siest G (1983) Plasma lecithin: cholesterol acyltransferase - reference values and effects of xenobiotics. Clin Chim Acta 133:85-96
33. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275
34. Lausada NR, de Gomez Dumm IN, Camihort G, Raimondi JC (2002) Lipid pattern in kidney-transplanted rats without immunosuppressive therapy. Transplant Proc 34:380-383
35. Hulzebos CV, Bijleveld CM, Stellaard F, Kuipers F, Fidler V, Slooff MJ, Peeters PM, Sauer PJ, Verkade HJ (2004) Cyclosporine A-induced reduction of bile salt synthesis associated with increased plasma lipids in children after liver transplantation. Liver Transplant 10:872-880
36. Mathis AS, Dave N, Knipp GT, Friedman GS (2004) Drug-related dyslipidemia after renal transplantation. Am J Health Syst Pharm 61:565-585
37. Galan AI, Roman ID, Munoz ME, Cava F, Gonzalez-Buitrago JM, Esteller A, Jimenez R (1992) Inhibition of biliary lipid and protein secretion by cyclosporine A in the rat. Biochem Pharmacol 44:1105-1113
38. Tsuboi K, Tazuma S, Ochi H, Chayama K (2003) Hydrophilic bile salts have a cytoprotective effect against cyclosporine A-induced cholestasis through enhanced canalicular membrane fluidity and transporter activity. Hepatol Res 25:38-47
39. Ichimaru N, Takahara S, Kokado Y, Wang JD, Hatori M, Kameoka H, Inoue T, Okuyama A (2001) Changes in lipid metabolism and effect of simvastatin in renal transplant recipients induced by cyclosporine or tacrolimus. Atherosclerosis 158:417-423
40. Song KH, Lee WJ, Koh JM, Kim HS, Youn JY, Park HS, Koh EH, Kim MS, Youn JH, Lee KU, Park JY (2005) alpha-Lipoic acid prevents diabetes mellitus in diabetes-prone obese rats. Biochem Biophys Res Commun 326:197-202
41. Vaziri ND, Liang K (1996) Down-regulation of tissue lipoprotein lipase expression in experimental chronic renal failure. Kidney Int 50:1928-1935
42. Proudlock JW, Day AJ (1972) Cholesterol esterifying enzymes of atherosclerotic rabbit intima. Biochim Biophys Acta 260:716-723
43. Newmark SR, Anderson CF, Donadio JV, Ellefson RD (1975) Lipoprotein profiles in adult nephrotics. Mayo Clin Proc 50:359-364
44. Dietschy JM (1995) Experimental mechanism: Regulation of plasma LDL cholesterol. Am J Clin Nutr 62:679S-688S
45. Mochizuki K, Oda H, Yokogoshi H (1998) Increasing effect of dietary taurine on the serum HDL cholesterol concentration in rats. Biosci Biotech Biochem 62:578-579
46. Packer L, Witt EH, Tritschler HJ (1995) alpha-Lipoic acid as a biological antioxidant. Free Radical Biol Med 19:227-250
47. Bustamante J, Lodge JK, Marcocci L, Tritschler HJ, Packer L, Rihn BH (1998) Alpha-lipoic acid in liver metabolism and disease. Free Radical Biol Med 24:1023-1039
48. Ford I, Cotter MA, Cameron NE, Greaves M (2001) The effects of treatment with alpha-lipoic acid or evening primrose oil on vascular hemostatic and lipid risk factors, blood flow, and peripheral nerve conduction in the streptozotocin-diabetic rat. Metabolism 50:868-875
49. Wollin SD, Wang Y, Kubow S, Jones PJ (2004) Effects of a medium chain triglyceride oil mixture and alpha-lipoic acid diet on body composition, antioxidant status, and plasma lipid levels in the Golden Syrian hamster. J Nutr Biochem 15:402-410
50. Thirunavukkarasu V, Anitha Nandhini AT, Anuradha CV (2004) Effect of alpha-lipoic acid on lipid profile in rats fed a high-fructose diet. Exp Diabesity Res 25:195-200